2FERRARI S,MUDDE GC,RIEGER M,et al.IgG subclass distributionof anti-ADAMTS13 antibodies in patients with acquired thromboticthrombocytopenic purpura M. Journal of Thrombosis and Haemostasis . 2009 被引量：1
3DE GROOT R,BARDHAN A,RAMROOP N,et al.Essential role ofthe disintegrin-like domain in ADAMTS13 function. Blood . 2009 被引量：1
4KOKAME K,MATSUMOTO M,FUJIMURA Y,et al.VWF73,a re-gion from D1596 to R1668 of von Willebrand factor,provides a mini-mal substrate for ADAMTS-13. Blood . 2004 被引量：1
6Turner,N. et al.Human endothelial cells synthesize and release ADAMTS-13. Journal of Thrombosis and Haemostasis . 2006 被引量：1
7Nancy A Turner,,Leticia Nolasco,Zaverio M. Ruggeri,Joel L. Moakel.Endothelial cellADAMTS-13 and VWF:production, release, and VWF string Cleavage. Blood . 2009 被引量：1
9Moore I,Strain L,Pappworth I,et al.Association of factor H autoantibodies with deletions of CFHR1,CFHR3,CFHR4 and with mutations in CFH,CFI,CD46,and C3 in patients with atypical haemolytic uraemic syndrome. Blood . 2010 被引量：1
10M Delvaeye,M Noris,A Vriese,CT Esmon,NL Esmon,G Ferrell,J Del-Favero,S Plaisance,B Claes,D Lambrechts,C Zoja,G Remuzzi,EM Conway.Thrombomodulin mutations in atypical hemolytic-uremic syndrome. The New England Journal of Medicine . 2009 被引量：1
